Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis

BACKGROUND: Combination therapy with immune checkpoint inhibitors (ICIs) and antiangiogenic agents is generally effective and well tolerated and might be effective for metastatic urothelial carcinoma (UC). However, ICI treatment is often associated with unique responses, such as pseudoprogression an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zizhong, Zhang, Guoqing, Sun, Qiong, Liu, Minglu, Shao, Jiakang, Jiao, Shunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884808/
https://www.ncbi.nlm.nih.gov/pubmed/33604293
http://dx.doi.org/10.3389/fonc.2020.611810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884808/
https://www.ncbi.nlm.nih.gov/pubmed/33604293
http://dx.doi.org/10.3389/fonc.2020.611810

Ejemplares similares